share_log

三葉草生物-B：截至2024年8月31日止股份發行人的證券變動月報表

CLOVER BIO-B: Monthly Return of Equity Issuer on Movements in Securities for the month ended 31 August 2024

HKEX ·  Sep 3 11:48

Summary by Futu AI

三葉草生物製藥有限公司（三叶草生物-B）於2024年9月3日向香港交易及結算所有限公司提交了最新的證券變動月報表，報告截至2024年8月31日的股份變動情況。報告顯示，公司的法定/註冊股本及已發行股份（不包括庫存股份）在報告期內均無變動，維持在2,000,000,000股普通股，每股面值0.0001美元，法定/註冊股本總額為200,000美元，已發行股份總數為1,297,048,929股。此外，公司的股份期權計劃中，首次公開發售前購股權計劃及首次公開發售後購股權計劃在本月內分別有4,000股及3,195,992股股份期權失效，但未有新股因行使期權而發行。公司確認所有證券發行或庫存股份出售或轉讓均已獲董事會授權並遵守相關規定。
三葉草生物製藥有限公司（三叶草生物-B）於2024年9月3日向香港交易及結算所有限公司提交了最新的證券變動月報表，報告截至2024年8月31日的股份變動情況。報告顯示，公司的法定/註冊股本及已發行股份（不包括庫存股份）在報告期內均無變動，維持在2,000,000,000股普通股，每股面值0.0001美元，法定/註冊股本總額為200,000美元，已發行股份總數為1,297,048,929股。此外，公司的股份期權計劃中，首次公開發售前購股權計劃及首次公開發售後購股權計劃在本月內分別有4,000股及3,195,992股股份期權失效，但未有新股因行使期權而發行。公司確認所有證券發行或庫存股份出售或轉讓均已獲董事會授權並遵守相關規定。
On September 3, 2024, Trifolium Biopharmaceuticals Limited (Trifolium Biopharm-B) submitted its latest monthly statement of securities changes to Hong Kong Exchanges and Clearing Limited, reporting the share changes as of August 31, 2024. The report shows that the company's authorized/registered share capital and issued shares (excluding treasury shares) remained unchanged during the reporting period, maintaining at 2,000,000,000 ordinary shares with a par value of $0.0001 per share. The total authorized/registered share capital is $200,000, and the total issued shares amount to 1,297,048,929 shares. In addition, the company's stock option plans saw 4,000 options and 3,195,992 options expire in the current month for the pre-IPO stock option plan and the post-IPO stock option plan respectively, but no new shares were issued as a result of exercising the options. The company confirms that all securities issuances or treasury shares sales or transfers have been authorized by the board of directors and comply with relevant regulations.
On September 3, 2024, Trifolium Biopharmaceuticals Limited (Trifolium Biopharm-B) submitted its latest monthly statement of securities changes to Hong Kong Exchanges and Clearing Limited, reporting the share changes as of August 31, 2024. The report shows that the company's authorized/registered share capital and issued shares (excluding treasury shares) remained unchanged during the reporting period, maintaining at 2,000,000,000 ordinary shares with a par value of $0.0001 per share. The total authorized/registered share capital is $200,000, and the total issued shares amount to 1,297,048,929 shares. In addition, the company's stock option plans saw 4,000 options and 3,195,992 options expire in the current month for the pre-IPO stock option plan and the post-IPO stock option plan respectively, but no new shares were issued as a result of exercising the options. The company confirms that all securities issuances or treasury shares sales or transfers have been authorized by the board of directors and comply with relevant regulations.
Helpful
Not Helpful

This announcement is a separate document:

Doc 1     View Translation

The translation is provided by third-party software.


The information provided by Futu AI is automatically generated by third-party artificial intelligence (AI) software based on news content. It is only available to users located outside of China mainland.


The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.
    Heat List
    US
    SymbolLatest Price% Chg

    No Data

    Hot News
    Updated